WOCKHARDT GROUP ASSETS UP FOR GRABS

The Wockhardt Group, previously a prominent player in the pharmaceutical industry, is facing financial distress. With mounting debts and a struggling business, the group's significant assets are now headed to market. This dramatic turn of events has sent shockwaves through the industry, spurring speculation within financial circles. It remains unk